HCFA Names MCAC Diagnostic Imaging Panel, Sets Lab Services Panel Date
This article was originally published in The Gray Sheet
Executive Summary
Jeffrey Lerner, PhD, VP-strategic planning, ECRI, will serve as a temporary voting member at the first meeting of the drugs, biologics and therapeutics panel of the Health Care Financing Administration's Medicare Coverage Advisory Committee (MCAC), scheduled for Sept. 15-16.